Salvage treatment for patients with acute myelogenous leukemia treated after intensive induction therapy by daunorubicin.

被引：0
|
作者：
Dobashi, N
Usui, N
Asai, O
Yano, S
Uno, S
Watanabe, H
Katori, M
Yahagi, Y
Nagamine, M
Saito, T
Yamaguchi, Y
Kasama, K
Tajima, N
Yamazaki, H
Kobayashi, T
Kuraishi, Y
机构：
[1] Jikei Univ Hosp, Dept Hematol & Oncol, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3897
引用
收藏
页码：209B / 209B
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH EARLY INTENSIVE INDUCTION THERAPY
    JOHNSON, SA
    PRENTICE, AG
    PHILLIPS, MJ
    ACTA ONCOLOGICA, 1988, 27 (05) : 527 - 529
  • [22] Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy
    Vey, N
    Keating, M
    Giles, F
    Cortes, J
    Beran, M
    Estey, E
    BLOOD, 1999, 93 (09) : 3149 - 3150
  • [23] INDUCTION THERAPY AND INTENSIFIED CONSOLIDATION THERAPY OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    KURRLE, E
    EHNINGER, G
    FREUND, M
    HEIL, G
    HOELZER, D
    LINK, H
    MITROU, PS
    OHL, S
    QUEISSER, W
    SCHLIMOK, G
    WANDT, H
    ONKOLOGIE, 1988, 11 (01): : 5 - 9
  • [24] INFLUENCE OF DAUNORUBICIN AND CYTARABINE SEQUENCING ON THE OUTCOME OF THERAPY IN ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL
    ARCHIMBAUD, E
    FIERE, D
    TREILLERITOUET, D
    ADELEINE, P
    GUYOTAT, D
    SEBBAN, C
    VUVAN, H
    VIALA, JJ
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 571 - 574
  • [25] Results of Second Salvage Therapy in 673 Adults With Acute Myelogenous Leukemia Treated at a Single Institution Since 2000
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Nogueras-Gonzalez, Graciela M.
    Kadia, Tapan M.
    Jabbour, Elias
    Bueso-Ramos, Carlos E.
    O'Brien, Susan M.
    Konopleva, Marina
    Jain, Nitin B.
    Daver, Naval G.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Simkins, Aron
    Garcia-Manero, Guillermo
    Keating, Michael J.
    Huang, Xuelin
    Cortes, Jorge E.
    Pierce, Sherry A.
    Ravandi, Farhad
    Freireich, Emil J.
    CANCER, 2018, 124 (12) : 2534 - 2540
  • [26] SNPing away to individualize induction therapy for acute myelogenous leukemia
    Kaplan, Jason B.
    Altman, Jessica K.
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 742 - 743
  • [27] LITHIUM AND GRANULOCYTOPENIA DURING INDUCTION THERAPY OF ACUTE MYELOGENOUS LEUKEMIA
    STEIN, RS
    FLEXNER, JM
    GRABER, SE
    BLOOD, 1979, 54 (03) : 636 - 641
  • [28] LITHIUM AND GRANULOCYTOPENIA DURING INDUCTION THERAPY OF ACUTE MYELOGENOUS LEUKEMIA
    STEIN, RS
    FLEXNER, JM
    GRABER, S
    CLINICAL RESEARCH, 1978, 26 (06): : A766 - A766
  • [29] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN OLDER PATIENTS
    FOON, KA
    ZIGHELBOIM, J
    GALE, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (24): : 1470 - 1470
  • [30] THE EFFECTIVENESS OF INTENSIVE CHEMOTHERAPY TO THE ELDERLY ACUTE MYELOGENOUS LEUKEMIA PATIENTS
    Kim, D.
    Choi, C.
    Park, Y.
    Lee, S.
    Sung, H.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 529 - 529
12345